Pediatric Drug Development Concepts and Applications 2e

Pediatric Drug Development Concepts and Applications 2e

Publisher

Wiley – Blackwell

Language

‎English

Edition

2nd

ISBN-10

1118312155

ISBN-13

978-1118312155

$21.00

5/5
Description

Pediatric Drug Development Concepts and Applications 2e

Pediatric Drug Development Concepts and Applications 2e” is a comprehensive resource that addresses the evolving regulatory landscape in the European Union (EU), United States (US), and the rest of the world (ROW), all aimed at facilitating the development of safe and effective medications for children.

This second edition incorporates the latest advancements in the field, particularly in areas like biomarkers, surrogate endpoints, developmental pharmacology, and other innovative aspects of pediatric drug development.

Pediatric Drug Development Concepts and Applications 2e critically examines the initiatives and frameworks designed to enhance access to pediatric medicines while ensuring their safety and efficacy, making it an essential reference for professionals involved in pediatric drug research and regulation.

Pediatric Drug Development Concepts and Applications 2e

Pediatric Drug Development Concepts and Applications 2e

1.2.Key Features

The key features of “Pediatric Drug Development Concepts and Applications 2e” that set it apart as a valuable resource in the field of pediatric pharmacology and drug development include:

  1. Comprehensive Regulatory Coverage: Pediatric Drug Development Concepts and Applications 2e extensively covers the regulatory initiatives and frameworks in the EU, US, and ROW aimed at improving access to safe and effective medications for children. This up-to-date information is crucial for researchers, clinicians, and regulators.
  2. Focus on Novel Developments: The second edition of the book incorporates the latest advancements in pediatric drug development, including discussions on biomarkers, surrogate endpoints, and developmental pharmacology. These topics reflect the cutting-edge research and strategies in the field.
  3. Practical Applications: Pediatric Drug Development Concepts and Applications 2e not only provides theoretical insights but also offers practical applications and concepts in pediatric drug development. This makes it a valuable guide for professionals involved in the actual process of developing and evaluating pediatric medications.
  4. Safety and Efficacy: Pediatric Drug Development Concepts and Applications 2e emphasizes the paramount importance of ensuring the safety and efficacy of drugs for children, addressing the unique challenges and considerations in pediatric pharmacology, making it a reliable reference for those concerned with pediatric healthcare.
  5. Access to Medications: With a focus on initiatives to enhance access to pediatric medicines, this resource is invaluable for professionals seeking to contribute to the development of treatments specifically tailored to children’s needs.
  6. Up-to-Date Information: Given the ever-evolving nature of regulatory guidelines and pharmacological research, this second edition provides readers with the most current and relevant information in the field.
Pediatric Drug Development Concepts and Applications 2e

Pediatric Drug Development Concepts and Applications 2e

1.3. about Writer

Andrew E. Mulberg, Lisa L. Mathis, Dianne Murphy, and Julia Dunne collectively represent a distinguished group of experts in the field of pediatric pharmacology and healthcare.

Dr. Andrew E. Mulberg, a prominent figure in pediatric drug development, has made significant contributions to the understanding of drug safety and efficacy in children, particularly in his role at the U.S. Food and Drug Administration (FDA).

Dr. Lisa L. Mathis, renowned for her expertise in pediatric regulatory affairs, has played a pivotal role in shaping regulatory policies aimed at ensuring the availability of safe and effective medications for children.

Dr. Dianne Murphy, with her extensive background in pediatric clinical pharmacology, has advanced our knowledge of pediatric drug dosing and pharmacokinetics.

Julia Dunne, known for her contributions to pediatric clinical trials, has been instrumental in the development and evaluation of medications for pediatric patients.

Together, they have collectively enriched the field of pediatric pharmacology, improving healthcare outcomes for children worldwide.

Pediatric Drug Development Concepts and Applications 2e

Pediatric Drug Development Concepts and Applications 2e

Summary

Pediatric Drug Development Concepts and Applications 2e” is a comprehensive and essential resource in the field of pediatric pharmacology and drug development.

This book delves into the evolving regulatory landscape across the European Union (EU), United States (US), and the rest of the world (ROW), addressing the crucial initiatives designed to improve access to safe and effective medications tailored for children.

Pediatric Drug Development Concepts and Applications 2e focus on cutting-edge topics such as biomarkers, surrogate endpoints, and developmental pharmacology reflects the latest advancements in pediatric drug research.

Beyond theory, Pediatric Drug Development Concepts and Applications 2e emphasizes practical applications and the critical importance of ensuring the safety and efficacy of pediatric medications.

With a spotlight on access to medicines, it serves as a vital guide for professionals navigating the complexities of pediatric drug development and regulation, offering current insights and strategies to enhance pediatric healthcare.

 

Make sure that you are buying e-books from trustworthy sources. With over a decade of experience in the e-book industry, the Medbook1.com website is a reliable option for your purchase.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Pediatric Drug Development Concepts and Applications 2e”

Your email address will not be published. Required fields are marked *